Publications: 1978 - 1989
|
Fletcher S, Ratzer G, Pollak M. Computer-based appointment scheduling for ambulatory patients. Meth Information Med 17: 167-72, 1978. |
|
|
Pollak M. Computer-aided information management systems in clinical trials: a physician's perspective. Computer Prog Biomed 16: 243-52, 1983. |
|
|
Buick RN, and Pollak MN. Perspectives on clonogenic tumor cells, stem cells, and oncogenes. Cancer Research 44: 4909-18, 1984. |
|
|
Filmus J, Pollak MN, Cairncross J, Buick RN. Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line. Biochem Biophys Res Commun. 131: 207-215, 1985. |
|
|
Filmus J, Pollak MN, Cailleau R, Buick RN. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 128: 898-905, 1985. |
|
|
Pollak M, Perdue J, Margolese R, Baer K, Richard M. Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Letters 38: 223-230, 1987. |
|
|
Filmus J, Trent JM, Pollak MN, Buick RN. Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. Mol and Cell Biol 7: 251-257, 1987. |
|
|
Gonzalez-Vela JL, Panasci L, Black M, Pollak M, Margolese R. Combination chemotherapy with carboplatinum and bleomycin for advanced and recurrent head and neck cancer. A phase II study. J. Surgical Oncology 39: 215-6, 1988. |
|
|
Pollak M, Polychronakos C, Yousefi S, Richard M. Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 154: 326-31, 1988. |
|
|
Pollak M, Polychronakos C, Guyda H. Somatostatin analogue SMS 201-995 reduces serum IGF-1 levels in patients with neoplasms potentially dependent on IGF-1. Anticancer Research 9: 889-891, 1989. |
|
|
Suissa S, Pollak M, Spitzer W, Margolese R. Body size and breast cancer prognosis: a statistical explanation of the discrepancies. Cancer Research 49: 3113-6, 1989. |